Pancytopenia as a Complication of Low-Dose Methotrexate in a Septuagenarian: A Rare Presentation

Methotrexate (MTX) is an antimetabolite that was initially developed as a chemotherapeutic agent to treat malignancies but later used extensively to treat rheumatological conditions. MTX-induced toxicity is dose- and duration-dependent. Myelosuppression is a rare but fatal complication of MTX that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanderi, Tejaswi, Chan Gomez, Janet, Puthenpura, Max M, Yarlagadda, Keerthi, Gangireddy, Mounika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Medical Education
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343297/
https://www.ncbi.nlm.nih.gov/pubmed/32656010
http://dx.doi.org/10.7759/cureus.8492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343297/
https://www.ncbi.nlm.nih.gov/pubmed/32656010
http://dx.doi.org/10.7759/cureus.8492

Ejemplares similares